Advances in Immunotherapy for Glioblastoma Multiforme.

Boyuan Huang1, Hongbo Zhang2, Lijuan Gu3

  • 1Department of Neurosurgery, Beijing Electric Hospital, State Grid, Beijing 100073, China.

Summary

Glioblastoma multiforme (GBM) treatment combines surgery, radiation, and chemotherapy, but outcomes remain poor. Emerging immunotherapies, including cancer vaccines and checkpoint inhibitors, show promise for improving glioblastoma survival rates.

Related Concept Videos